TARS 8-K 2026-07-13

Tarsus Pharmaceuticals, Inc. (TARS) 8-K dated 2026-07-13 — accession 0001819790-26-000048. This URL is the filing, not the TARS hub.

Tarsus Pharmaceuticals, Inc. (TARS) is a biotechnology company listed on NASDAQ.

Tarsus Pharmaceuticals, Inc. filed a 8-K on 2026-07-13. Accession 0001819790-26-000048.

Cached items: 5.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported TARS revenue for 2026-06-30 was $336.0M. Net income was -$25.5M. TARS currently screens at market cap $2.66B.

Not investment advice. The TARS SEC hub lists recent forms. The stock page is the research view.